NCT03370536 - ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

July 18, 2018

Study Completion Date

July 18, 2018

Conditions

Atrial FibrillationPersistent Atrial Fibrillation

Interventions

DEVICE

CardioInsight ECGI Mapping System

The CardioInsight mapping system is a noninvasive, single beat cardiac arrhythmia mapping system that provides 3D electroanatomic maps of the heart.

PROCEDURE

AF ablation

Empiric ablation (CFAE or linear ablation) is not permitted

DRUG

Ibutilide

Progressive doses of Ibutilide administered (0.25mg, then 0.25mg, then 0.5mg)

Trial Locations (1)

Icahn School of Medicine at Mount Sinai, New York